https://medicine.ouhsc.edu/news Parent Page: News id: -1 Active Page: Newsid:22450

College News

Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study published today in the journal Science Signaling reveals a new understanding of how amylin receptors react upon being activated, an advancement that will be crucial to the field of drug development.

Read more >

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among people with low incomes, leading to health disparities. A smartphone app that delivers real-time, tailored messages may hold the key to helping them quit, according to University of Oklahoma clinical trial results published today in JAMA Network Open.

Read more >

University of Oklahoma researchers are conducting a first-of-its-kind study to determine whether cannabis use affects recovery from the wounds associated with head and neck cancer surgery. The outcomes may have implications for other types of surgery and conditions.

Read more >

Motolani Adedipe, Ph.D., associate professor in the Department of Family and Preventive Medicine at the University of Oklahoma Health Sciences Center, has been awarded a Fulbright U.S. Scholar award to South Korea through the U.S.-Korea Presidential STEM Initiative.

Read more >

Pregnant women with chronic conditions like obesity and diabetes face a significantly higher risk of delivering preterm babies. These babies, especially those born very early, often experience serious health complications at birth – many of which can persist into adulthood, creating a cycle of poor health that can be difficult to interrupt.

Read more >
First11Last